Acute respiratory failure in children

Current Opinion in Pediatrics

Volumn 12, Issue 3, 2000, Pages 233-237

  Bateman, Scot T ^a   Arnold, John H ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; SURFACTANT;

ACUTE RESPIRATORY FAILURE; ARTICLE; ARTIFICIAL VENTILATION; IMMUNOMODULATION; LEUKOCYTE ADHERENCE; LUNG INJURY; NEUTROPHIL; OXIDATIVE STRESS; POSITIVE END EXPIRATORY PRESSURE; PRIORITY JOURNAL; SURVIVAL; TIDAL VOLUME;

ACUTE DISEASE; ADULT; ANIMALS; CHILD; HUMANS; INFANT, NEWBORN; INTENSIVE CARE; LUNG; RESPIRATORY INSUFFICIENCY; RISK FACTORS; SURVIVAL RATE; VENTILATORS, MECHANICAL;

EID: 0034072357     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200006000-00010     Document Type: Article

References (18)

1. 1 Doyle RL, Szaflarski N, Modin GW, Wiener-Kronish JP, Matthay MA: Identification of patients with acute lung injury: Predictors of mortality. Am J Respir Crit Care Med 1995, 152:1818-1824.
2. 2 Monchi M, Bellenfant F, Cariou A, Joly L, Thebert D, Laurent I, et al.: Early predictive factors of survival in the acute respiratory distress syndrome. Am J Respir Crit Care Med 1998, 158:1076-1081.
3. 3 Ranieri VM, Suter PM, Tortorella C, De Tullio R, Dayer JM, Brienza A, et al.: Effect of mechanical ventilation on inflammatory mediators in patients with acute respiratory distress syndrome: a randomized controlled trial. JAMA 1999, 282:54-61. This well-conducted clinical trial is essential reading and provides direct evidence in humans of ventilator-associated lung injury. These data provide a firm rationale for defining "lung-protective" conventional ventilation.
4. 4 National Institute of Health/National Heart, Lung, and Blood Institute ARDS network. Available at: http://hedwig.mgh.harvard.edu/ardsnet/nih.html. Accessed December 15, 1999. This article presents preliminary data from the ARDSNet investigators that demonstrates a significant improvement in mortality in patients managed with limited tidal volumes. The use of PEEP was uncontrolled in this protocol and closer scrutiny of these data will be important once the final results have been published.
5. 5 Gattinoni L, Pelosi P, Suter PM: Acute respiratory distress syndrome caused by pulmonary disease and extra pulmonary disease: different syndromes? Am J Respir Crit Care Med 1998, 158:3-11. This is an interesting hypothesis from some of the principals in the field of adult critical care, which may explain some of the inconsistencies in previous clinical trials that failed to specify primary versus secondary pulmonary disease.
6. 6 Kinsella JP, Truog WE, Walsh WF, Goldberg RN, Bancalari E, Mayock DE, et al.: Randomized, multicenter trial of inhaled nitric oxide and high-frequency oscillatory ventilation in severe, persistent pulmonary hypertension of the newborn. J Pediatrics 1997, 131:55-62.
7. 7 Ream RS, Hauver JF, Lynch RE, Kountzman B, Gale GB, Mink RB: Low-dose inhaled nitric oxide imporves the oxygenation and ventilation of infants and children with acute, hypoxemic respiratory failure. Crit Care Med 1999, 27:989-996.
8. 8 Dobyns EL, Cornfiled DM, Anas NG, Fortenberry JD, Tasker RC, Lynch A, et al.: Multicenter randomized controlled trial of the effects of inhaled nitric oxide therapy on gas exchange in children with acute hypoxemic respiratory failure. J Pediatr 1999, 134:406-412.
9. 9 Davidson D, Barefield ES, Kattwinkel J, Dudell G, Damask M, Straube R, et al.: Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. Pediatrics 1999, 104:231-236. This is an interesting report regarding patients treated with iNO, which should add a note of caution to the current enthusiasm for nitric oxide in almost any disease entity.
10. 10 Atz AM, Wessel DL: Sildenafil ameliorates effects of inhaled nitric oxide withdrawal. Anesthesiology 1999, 91:307-310.
11. 11 Willson DF, Zaritsky A, Bauman LA, Dockery K, James RL, Conrad D, et al.: Instillation of calf lung surfactant extract (calfactant) is beneficial in pediatric acute hypoxemic respiratory failure. Crit Care Med 1999, 27:188-195. This is an important study in the evolving sequence of clinical trials examining the use of exogenous surfactant. It is the first randomized trial in the pediatric (nonneonatal, nonadult) population and it is hoped that it will be followed by a larger multicenter trial by the same group.
12. 12 Masiakos PT, Islam S, Doody DP, Schnitzer JJ, Ryan DP: Extracorporeal membrane oxygenation for nonneonatal acute respiratory failure. Arch Surg 1999, 134:375-379. This is an interesting description of non-neonatal ECMO from a single center, and represents the most recent information regarding the use of extracorporeal life support in the pediatric population.
13. 13 Rossi R, Shemie SD, Calderwood S: Prognosis of pediatric bone marrow transplant recipients requiring mechanical ventilation. Crit Care Med 1999, 27:1181-1186. This series from a single large center represents a significant improvement in outcomes compared with previous reports. Possible explanations include early and aggressive use of mechanical ventilation as well as improvements in standard supportive care for this population.
14. 14 Lamb NJ, Gutteridge JM, Baker C, Evans TW, Quinlan GJ: Oxidative damage to proteins of bronchoalveolar lavage fluid in patients with acute respiratory distress syndrome: evidence for neutrophil-mediated hydoxylation, nitration, and chlorination. Crit Care Med 1999, 27:1738-1744.
15. 15 Gadek JE, DeMichele SJ, Karlstad MD, Pacht ER, Donahoe M, Albertson TE, et al.: Effect of enterai feeding with eicosapentaenoic acid, gammalinolenic acid, and antioxidants in patients with acute respiratory distress syndrome. Crit Care Med 1999, 27:1409-1420.
16. 16 Abraham E, Baughman R, Reicher E, Heard S, Lamberti J, Levy H, et al.: Liposomal prostaglandin E1 (TLC C-53) in acute respiratory distress syndrome: a controlled, randomized, double-blind, multicenter clinical trial. Crit Care Med 1999, 27:1478-1485.
17. 17 Meduri GU, Headley AS, Golden E, Carson SJ, Umberger RA, Kelso T, Tolley EA: Effect of prolonged methyprednisolone therapy in unresolving acute respiratory distress syndrome: a randomized controlled trial. JAMA 1998, 280:159-165. This small controlled trial is the first randomized, controlled trial to show benefit of corticosteroids used late in the course of ARDS. The treatment period is quite lengthy and necessitates continuous vigilance for infection.
18. 18 Davidson TA, Caldwell ES, Curtis JR, Hudson LD, Steinberg KP: Reduced quality of life in survivors of acute respiratory distress syndrome compared with critically ill control patients. JAMA 1999, 281:354-360.